Abstract
To compare the efficacy and safety of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) in patients without heart failure. Meta-analysis of randomized trials identified using PubMed, Embase, and Cochrane Central Register of Controlled Trials searches from January 1, 1980, through April 13, 2015, of ACEis and ARBs compared with placebo or active controls and corroborated with head-to-head trials of ARBs vs ACEis. Outcomes were all-cause mortality, cardiovascular death, myocardial infarction (MI), angina, stroke, heart failure, revascularization, and new-onset diabetes. Our search yielded 106 randomized trials that enrolled 254,301 patients. Compared with placebo, ACEis but not ARBs reduced the outcomes of all-cause mortality (ACEis vs placebo: relative risk [RR], 0.89; 95% CI, 0.80-1.00; ARBs vs placebo: RR, 1.01; 95% CI, 0.96-1.06; Pinteraction=.04), cardiovascular death (RR, 0.83; 95% CI, 0.70-0.99 and RR, 1.02; 95% CI, 0.92-1.14; Pinteraction=.05), and MI (RR, 0.83; 95% CI, 0.78-0.90 and RR, 0.93; 95% CI, 0.85-1.03; Pinteraction=.06). The meta-regression analysis revealed that the difference between ACEis and ARBs compared with placebo was due to a higher placebo event rate in the ACEis...Continue Reading
References
Aug 1, 1988·Statistics in Medicine·R F Galbraith
Jan 1, 1988·Archives of Internal Medicine
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Dec 10, 1999·Lancet·D MoherD F Stroup
Sep 19, 2003·Lancet·K M Fox, UNKNOWN EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
May 26, 2004·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jul 14, 2004·Circulation·Scott M GrundyUNKNOWN American Heart Association
Sep 19, 2006·The New England Journal of Medicine·UNKNOWN DREAM Trial InvestigatorsRury R Holman
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Aug 30, 2008·The New England Journal of Medicine·Salim YusufUNKNOWN PRoFESS Study Group
Sep 9, 2008·Current Hypertension Reports·Donald G Vidt
May 21, 2009·BMJ : British Medical Journal·M R LawN J Wald
Mar 11, 2011·The New England Journal of Medicine·Hermann HallerUNKNOWN ROADMAP Trial Investigators
Jul 20, 2011·Expert Opinion on Pharmacotherapy·Guido Grassi
Jul 30, 2014·Circulation·Stephan D FihnPeter K Smith
Citations
Jul 6, 2016·Mayo Clinic Proceedings·Jean-Jacques Mourad
Jul 6, 2016·Mayo Clinic Proceedings·Sripal BangaloreFranz H Messerli
Oct 25, 2016·The American Journal of Cardiology·Chirag BavishiFranz H Messerli
Sep 23, 2016·The New England Journal of Medicine·Eva M LonnSalim Yusuf
Oct 26, 2016·Progress in Cardiovascular Diseases·Chirag BavishiFranz H Messerli
Oct 26, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Seema Patel
Mar 28, 2017·Current Opinion in Cardiology·Monica Ahluwalia, Sripal Bangalore
Nov 3, 2017·Journal of Hypertension·Louis HofstetterFranz H Messerli
Jan 19, 2018·Expert Review of Clinical Pharmacology·Julie Rask LarsenPeter Manu
Aug 18, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Fadia MayyasAnan Jarab
May 31, 2018·Hypertension·Franz H MesserliEmrush Rexhaj
Jun 1, 2017·Circulation·Franz H Messerli, Sripal Bangalore
Jun 1, 2017·Circulation·Martin H Strauss, Alistair S Hall
Nov 7, 2019·Angiology·Yong Hoon KimYangsoo Jang
Sep 13, 2019·Heart Failure Reviews·Nicola Riccardo PuglieseStefano Taddei
Feb 23, 2020·Journal of Clinical Medicine·Michelle L LawJoseph M Metzger
Apr 10, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·François-Xavier LapébieVanina Bongard
Jun 21, 2019·Open Heart·Dennis KoCynthia Jackevicius
Jan 20, 2017·The New England Journal of Medicine·David C Goff, William C Cushman
Jan 26, 2017·PloS One·Yun Jung OhJi Yong Jung
Dec 29, 2018·Advances in Therapy·Stefano Omboni, Massimo Volpe
Apr 16, 2020·Journal of General Internal Medicine·Matthew AlcuskyKate L Lapane
Jul 22, 2020·Pharmacological Reports : PR·Agnieszka Łoboda, Józef Dulak
Aug 27, 2018·Systematic Reviews·Jonathan A BattyAlistair S Hall
Aug 10, 2020·Medicine·Jiahui WuChangsheng Ma
May 13, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·F FiciG Grassi
Feb 6, 2020·Scientific Reports·Jeayoun KimHyojin Cho
Aug 23, 2019·Current Drug Targets·Khuraijam Dhanachandra Singh, Sadashiva S Karnik
Apr 23, 2020·BMC Cardiovascular Disorders·Yara WanasLuis Furuya-Kanamori
Jul 11, 2020·Current Cardiology Reports·Jeffrey M Turner, Ravi Kodali
Aug 25, 2019·International Journal of Molecular Sciences·Tatyana A Meyers, DeWayne Townsend
Sep 23, 2016·The New England Journal of Medicine·Young-Hoon JeongSidney C Smith
Dec 19, 2020·Cardiovascular Drugs and Therapy·Maximilian TscharreThomas Gremmel
Jan 16, 2021·Journal of Diabetes and Its Complications·Xiao-Chun YangQing-Bao Tian
Oct 18, 2019·Mayo Clinic Proceedings·Yao QiaoMorgan E Grams
Apr 30, 2021·The New England Journal of Medicine·Maurizio GallieniPaolo Fiorina
Apr 30, 2021·The New England Journal of Medicine·Salim YusufPrem Pais
Apr 30, 2021·The New England Journal of Medicine·Miguel Cainzos-Achirica
Jun 12, 2021·Advances in Therapy·Riccardo SarzaniFrancesco Spannella
Oct 17, 2020·Future Cardiology·Sarah J Wang, Gary E Sander
Aug 28, 2021·Biomedicines·Francesca FortiniRoberto Ferrari
Sep 18, 2021·Cardiovascular Drugs and Therapy·Martin H StraussKrzysztof Narkiewicz
Dec 27, 2017·Canadian Journal of Diabetes·Martin H Strauss, Alistair S Hall
Sep 26, 2021·Journal of the Chinese Medical Association : JCMA·Chih-Wei ChenChun-Yao Huang